By engaging these pathways simultaneously, cagrilintide works to reduce food intake, increase satiety, and promote weight loss
Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis
The results reported a 6.0%, 6.8%, 9.1%, 9.7%, and 10.8% decrease in body weight for the groups receiving cagrilintide in doses of 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg, respectively [1]
Cagrilintide is a long-acting acylated analogue of amylin, a hormone co-secreted with insulin that regulates appetite and gastric emptying
If you're interested in exploring B12 injections for fatigue relief, consider contacting ThinWorks to schedule a consultation with one of our healthcare professionals
One vial per cycle